Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary F Mulcahy, MD
Northwestern University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
131 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical University of Vienna
Vienna, Austria
- Onze-Lieve-Vrouwziekenuis Vzw Campus Aalst
Aalst, Belgium
- Az - Sint Lucas
Ghent, Belgium
- Universitair Ziekenhuis Gent
Ghent, Belgium
- Az Groeninge
Kortrijk, Belgium
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Qeii Health Services Center, Halifax Infirmary Site
Halifax, Nova Scotia, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- University Health Network , Mount Sinai Hospital
Toronto, Ontario, Canada
- Mcgill University Health Center - Glen Site
Montreal, Quebec, Quebec, Canada
- Royal University Hospital
Saskatoon, Saskatchewan, Canada
- Hong Kong Sanatorium Hospital
Hong Kong, China
- Queen Mary Hospital
Hong Kong, China
- Chru Montpellier - Hopital St Eloi
Montpellier, Cedex 5, France
- Cuh D'Angers
Angers, Cedex 9, France
- Chu Toulouse, Hôpital Rangueil
Toulouse, Cedex 9, France
- Institut Bergognié
Bordeaux, France
- Hôpital Beaujon
Clichy, France
- Hôpital Henri Mondor
Créteil, France
- Centre Georges Francois Leclerc
Dijon, France
- Centre Hospitalier Lyon-Sud
Lyon, France
- Hôpital la Timone
Marseille, France
- Chu Nantes-Hôtel Dieu
Nantes, France
- Chu de Nice,, Hopital Archet 2 - Service D'Imagerie Médicale Niveau -2
Nice, France
- Chu Bordeaux
Pessac, France
- Hôpital la Milétrie, Chu Poitiers, Hépato Gastroenterologie
Poitiers, France
- Centre Eugene Marquis
Rennes, France
- Universitätsklinikum Bonn
Bonn, Germany
- Universitätsklinikum Essen
Essen, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- Slk Kliniken, Heilbronn Gmbh
Heilbronn, Germany
- Universitätsklinikum Des Saarlandes
Homburg, Germany
- University Hospital of Leipzig
Leipzig, Germany
- Universitaetsklinikum Marburg Klinik Für Dermatologie Und Allergologie
Marburg, Germany
- Eberhard-Karls-University Tübingen
Tübingen, Germany
- Azienda Ospedaliera-Universitaria, Policlinico Sant'Orsola Malpighi
Bologna, Italy
- Białostockie Centrum Onkologii
Bialystok, Poland
- Centrum Onkologii - Instytut, Im. Marii Skłodowskiej-Curie
Gliwice, Poland
- Regionalny Szpital Specjalistyczny Im. Dr Władysława Biegańskiego
Grudziądz, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2012
- Primary completion
- 31 Aug 2020
- Completion
- 31 Aug 2020
- Last update posted
- 29 Mar 2022
- Registered enrollment
- 428
- Registry id
- NCT01483027
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.